Skip to main content
. 2020 Aug 28;10(8):87. doi: 10.1038/s41408-020-00353-8

Fig. 2. Landmark Analysis showing Outcomes of Exceptional Responders to Autologous Stem Cell Transplantation (ASCT).

Fig. 2

A landmark analysis at 8 years after diagnosis of multiple myeloma showing the PFS (a), TTP (b), and OS (c) of exceptional responder patients.